Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
-
- Paul V. Fish
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- Panagis Filippakopoulos
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Gerwyn Bish
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- Paul E. Brennan
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Mark E. Bunnage
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- Andrew S. Cook
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- Oleg Federov
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Brian S. Gerstenberger
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Eastern Pont Road, Groton, Connecticut 06340, United States
-
- Hannah Jones
- Pfizer Worldwide R&D, 35/200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
-
- Stefan Knapp
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Brian Marsden
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Karl Nocka
- Pfizer Worldwide R&D, 35/200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
-
- Dafydd R. Owen
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- Martin Philpott
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Sarah Picaud
- Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom
-
- Michael J. Primiano
- Pfizer Worldwide R&D, 35/200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
-
- Michael J. Ralph
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- Nunzio Sciammetta
- Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
-
- John D. Trzupek
- Pfizer Worldwide R&D, 35/200 Cambridgepark Drive, Cambridge, Massachusetts 02140, United States
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 55 (22), 9831-9837, 2012-11-08
American Chemical Society (ACS)